Centre caps trade margin of anti-cancer drugs at 30%, SC asks why not other medicines
New Delhi: Supreme Court Monday said the Centre's response on capping the trade margin of anti-cancer drugs at 30 per cent of the maximum retail price (MRP) is "hardly anything to be happy about" and questioned why the government cannot cap trade margins of other...











































